IndraLab

Statements

Hydroxychloroquine decreases the amount of toll-like receptors. 2 / 2
| 2
reach
"It has been shown that the antimalarial drug hydroxychloroquine (Plaquenil) inhibits the expression of toll-like receptors (TLRs) and the production of IL-6, and hence may have an anti-COVID-19 impact (Wang et al., 2020)."
36506506
reach
"Interestingly, hydroxychloroquine (Plaquenil), an antimalarial drug, has also been reported to downregulate the expression of toll like receptors (TLRs) and IL-6 production, and therefore may have potential anti-COVID-19 activity [supplementary materials 3]."
32302707